Soft Tissue Disorder

Known as: Soft Tissue Diseases, Soft Tissue Disease, Disorders of soft tissue, unspecified 
A non-neoplastic or neoplastic disorder that affects the soft tissue.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1958-2017
0102019582017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PURPOSE Cabozantinib (XL184), an oral inhibitor of multiple receptor tyrosine kinases such as MET and VEGFR2, was evaluated in a… (More)
Is this relevant?
2011
2011
OBJECTIVES To determine the activity and tolerability of 100-mg once-daily (QD) dasatinib in patients with metastatic castration… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2009
2009
PURPOSE Irinotecan and temozolomide have single-agent activity and schedule-dependent synergy against neuroblastoma. Because… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE The development of tumor-specific markers to select targeted therapies and to assess clinical outcome remains a… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
1. Introduction Within the past decade, musculoskeletal ultra-sound (US) has become an established imaging technique for the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2000
2000
PURPOSE To determine immune responses and toxicity to the anti-idiotype vaccine, as well as clinical responses and survival, we… (More)
Is this relevant?
2000
2000
A retrospective analysis of 859 patients who developed bone metastases from breast cancer between 1975 and 1991 was performed in… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Serum concentrations of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-2 and IL-6 were determined by enzyme… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Tumor response after withdrawal of endocrine therapy for advanced breast cancer with estrogens and androgens is well described… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
PURPOSE Suramin is known to inhibit the growth of malignant prostate carcinoma cells in vitro. This led us to evaluate the… (More)
Is this relevant?